Now showing items 1-5 of 5

  • Accelerated hypofractionated radiotherapy schedules in breast cancer: A review of the current literature 

    Kalogeridi, M. A.; Kelekis, N.; Kouvaris, J.; Platoni, K.; Kyrias, G.; Pectasides, D.; Kouloulias, V. (2009)
    Lumpectomy followed by breast irradiation is an alternative to mastectomy for patients with early-stage breast cancer. The purpose of radiation treatment following lumpectomy is to minimize the risk of recurrent cancer in ...
  • Breast cancer: Follow-up with MRI after therapy 

    Kanavou, T.; Lazoura, O.; Tsilikas, K.; Karanikas, C.; Vassiou, K. (2009)
    Breast cancer is the most frequent malignancy in women worldwide. The incidence and mortality rates of the disease have increased the past few years, especially in richer countries that have adopted the mammographic screening ...
  • Current status of mechanical circulatory support: A systematic review 

    Spiliopoulos, K.; Giamouzis, G.; Karayannis, G.; Karangelis, D.; Koutsias, S.; Kalogeropoulos, A.; Georgiopoulou, V.; Skoularigis, J.; Butler, J.; Triposkiadis, F. (2012)
    Heart failure is a major public health problem and its management requires a significant amount of health care resources. Even with administration of the best available medical treatment, the mortality associated with the ...
  • Immunoglobulin D myeloma: Clinical features and outcome in the era of novel agents 

    Zagouri, F.; Kastritis, E.; Symeonidis, A. S.; Giannakoulas, N.; Katodritou, E.; Delimpasi, S.; Repousis, P.; Terpos, E.; Dimopoulos, M. A. (2014)
    Objectives: Immunoglobulin D (IgD) multiple myeloma is an uncommon variant of the disease probably associated with poorer prognosis. However, data on IgD myeloma patients treated in the novel agent era are lacking. Methods: ...
  • Melanoma: The Radiotherapeutic point of view; review of the current literature 

    Zygogianni, A.; Kyrgias, G.; Kouvaris, J.; Mystakidou, K.; Gogas, H.; Kouloulias, V. (2011)
    Surgery remains the mainstay of melanoma therapy at all sites. Melanoma is widely believed to be a radioresistant tumor, a misconception that has historically led to the limited use of RT for its treatment. We searched ...